{"id":459846,"date":"2026-01-09T13:25:00","date_gmt":"2026-01-09T12:25:00","guid":{"rendered":"https:\/\/medizinonline.com\/inhibition-de-lil-23-dans-le-psoriasis-du-cuir-chevelu-quoi-de-neuf\/"},"modified":"2026-01-09T14:41:33","modified_gmt":"2026-01-09T13:41:33","slug":"inhibition-de-lil-23-dans-le-psoriasis-du-cuir-chevelu-quoi-de-neuf","status":"publish","type":"post","link":"https:\/\/medizinonline.com\/fr\/inhibition-de-lil-23-dans-le-psoriasis-du-cuir-chevelu-quoi-de-neuf\/","title":{"rendered":"Inhibition de l’IL-23 dans le psoriasis du cuir chevelu : quoi de neuf ?"},"content":{"rendered":"\n

L’atteinte du cuir chevelu est fr\u00e9quente chez les patients atteints de psoriasis et peut induire une souffrance importante avec parfois un impact consid\u00e9rable sur la qualit\u00e9 de vie. Outre de nouveaux r\u00e9sultats d’\u00e9tudes sur les trois inhibiteurs \u00e9tablis de l’interleukine (IL) 23p19, le guselkumab, le tildrakizumab et le risankizumab, de nouvelles analyses post-hoc de donn\u00e9es de phase III sur le picankibart ont notamment \u00e9t\u00e9 pr\u00e9sent\u00e9es lors de la r\u00e9union annuelle de l’EADV de<\/em> cette ann\u00e9e. <\/strong><\/p>\n\n

Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich
Jetzt beitreten<\/a><\/div>
Already a member? Connectez-vous ici<\/a><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"

L’atteinte du cuir chevelu est fr\u00e9quente chez les patients atteints de psoriasis et peut induire une souffrance importante avec parfois un impact consid\u00e9rable sur la qualit\u00e9 de vie. Outre de……... <\/p>\n

Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich
Jetzt beitreten<\/a><\/div>
Already a member? Connectez-vous ici<\/a><\/div><\/div><\/div>","protected":false},"author":7,"featured_media":459847,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"pmpro_default_level":"","cat_1_feature_home_top":false,"cat_2_editor_pick":false,"csco_eyebrow_text":"Traitement du psoriasis bas\u00e9 sur les preuves dans les localisations difficiles","footnotes":""},"category":[11549,11362,11527,11535,11505],"tags":[87712,16604,18140,81463,87711,87716,14035,12957,26407,67793,87715,87713,87714],"powerkit_post_featured":[],"class_list":["post-459846","post","type-post","status-publish","format-standard","has-post-thumbnail","category-rx-fr","category-dermatologie-et-venerologie","category-etudes","category-rapports-de-congres","category-rhumatologie","tag-clear-1","tag-eadv-fr","tag-guselkumab-fr","tag-inhibition-de-lil-23","tag-localisations-difficiles","tag-picankibart","tag-psoriasis-fr-2","tag-psoriasis-capitis-fr","tag-risankizumab-fr","tag-tildrakizumab-fr","tag-unlimmited","tag-visible","tag-zodipso","pmpro-level-required","pmpro-level-1","pmpro-no-access"],"acf":[],"publishpress_future_action":{"enabled":false,"date":"2026-07-12 12:15:32","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"wpml_current_locale":"fr_FR","wpml_translations":{"it_IT":{"locale":"it_IT","id":459788,"slug":"inibizione-dellil-23-nella-psoriasi-del-cuoio-capelluto-cosa-ce-di-nuovo","post_title":"Inibizione dell'IL-23 nella psoriasi del cuoio capelluto: cosa c'\u00e8 di nuovo?","href":"https:\/\/medizinonline.com\/it\/inibizione-dellil-23-nella-psoriasi-del-cuoio-capelluto-cosa-ce-di-nuovo\/"},"pt_PT":{"locale":"pt_PT","id":459785,"slug":"inibicao-da-il-23-na-psoriase-do-couro-cabeludo-o-que-ha-de-novo","post_title":"Inibi\u00e7\u00e3o da IL-23 na psor\u00edase do couro cabeludo: o que h\u00e1 de novo?","href":"https:\/\/medizinonline.com\/pt-pt\/inibicao-da-il-23-na-psoriase-do-couro-cabeludo-o-que-ha-de-novo\/"},"es_ES":{"locale":"es_ES","id":459798,"slug":"inhibicion-de-la-il-23-en-la-psoriasis-del-cuero-cabelludo-que-hay-de-nuevo","post_title":"Inhibici\u00f3n de la IL-23 en la psoriasis del cuero cabelludo: \u00bfQu\u00e9 hay de nuevo?","href":"https:\/\/medizinonline.com\/es\/inhibicion-de-la-il-23-en-la-psoriasis-del-cuero-cabelludo-que-hay-de-nuevo\/"}},"_links":{"self":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts\/459846","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/comments?post=459846"}],"version-history":[{"count":1,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts\/459846\/revisions"}],"predecessor-version":[{"id":459848,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts\/459846\/revisions\/459848"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/media\/459847"}],"wp:attachment":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/media?parent=459846"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/category?post=459846"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/tags?post=459846"},{"taxonomy":"powerkit_post_featured","embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/powerkit_post_featured?post=459846"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}